The Society for Immunotherapy of Cancer (SITC) hosted “Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers” during the 35th Anniversary Annual Meeting & Pre-Conference Programs on November 14, 2020. Available here are the presentation slides and video from the session, as permitted by presenters.
35th Anniversary Annual Meeting Organizers
Session Co-Chairs
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Adnan A. Jaigirdar, MD, FACS – Food and Drug Administration; Date: November 14, 202000:18:34
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Rodabe N. Amaria, MD – The University of Texas MD Anderson Cancer Center; Date: November 14, 202000:15:03
Meeting: SITC 35th Anniversary Annual Meeting; Session 404: Next Generation Immunotherapy Combinations: Navigating FDA, Clinical Trial Design, Diagnostics and Novel Biomarkers; Presenter: Nicole Drezner, MD – Food and Drug Administration; Date: November 14, 202000:13:27
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us